Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 7 | 2021 | 1273 | 0.800 |
Why?
|
| Heart-Assist Devices | 4 | 2017 | 825 | 0.700 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 120 | 0.530 |
Why?
|
| Cardiac Catheterization | 4 | 2019 | 317 | 0.510 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2017 | 136 | 0.500 |
Why?
|
| Heart Ventricles | 2 | 2019 | 792 | 0.470 |
Why?
|
| Pneumonectomy | 2 | 2013 | 214 | 0.450 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 1132 | 0.440 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 303 | 0.410 |
Why?
|
| Survivors | 1 | 2013 | 191 | 0.390 |
Why?
|
| Popliteal Artery | 2 | 2020 | 29 | 0.340 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 2380 | 0.340 |
Why?
|
| Absorbable Implants | 2 | 2020 | 37 | 0.340 |
Why?
|
| Angioplasty, Balloon | 2 | 2020 | 98 | 0.330 |
Why?
|
| Peripheral Arterial Disease | 2 | 2020 | 98 | 0.310 |
Why?
|
| Hemodynamics | 4 | 2024 | 739 | 0.300 |
Why?
|
| Ischemia | 2 | 2020 | 254 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 1095 | 0.240 |
Why?
|
| Radial Artery | 2 | 2022 | 33 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1183 | 0.240 |
Why?
|
| Treatment Outcome | 9 | 2024 | 8436 | 0.230 |
Why?
|
| Retrospective Studies | 12 | 2023 | 9399 | 0.230 |
Why?
|
| Hypothermia, Induced | 1 | 2024 | 83 | 0.210 |
Why?
|
| Cysteine | 1 | 2024 | 144 | 0.210 |
Why?
|
| Myocardial Ischemia | 1 | 2024 | 165 | 0.200 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 126 | 0.200 |
Why?
|
| Ulnar Artery | 1 | 2022 | 5 | 0.200 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2013 | 478 | 0.180 |
Why?
|
| Chitosan | 1 | 2021 | 17 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 391 | 0.180 |
Why?
|
| Hemostatics | 1 | 2021 | 58 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 60 | 0.180 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2021 | 110 | 0.170 |
Why?
|
| Middle Aged | 11 | 2024 | 26555 | 0.170 |
Why?
|
| Male | 12 | 2024 | 43249 | 0.160 |
Why?
|
| Heart Transplantation | 2 | 2023 | 753 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 2 | 2013 | 396 | 0.160 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 374 | 0.160 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 51 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2019 | 70 | 0.160 |
Why?
|
| Female | 12 | 2024 | 47186 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 261 | 0.150 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 237 | 0.150 |
Why?
|
| Humans | 20 | 2024 | 91073 | 0.150 |
Why?
|
| Furosemide | 1 | 2018 | 35 | 0.150 |
Why?
|
| Diuretics | 1 | 2018 | 76 | 0.150 |
Why?
|
| Aged | 9 | 2024 | 19574 | 0.150 |
Why?
|
| Coronary Angiography | 3 | 2024 | 246 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 283 | 0.140 |
Why?
|
| Dopamine | 1 | 2018 | 273 | 0.140 |
Why?
|
| Adult | 7 | 2024 | 27147 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 129 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 482 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 148 | 0.110 |
Why?
|
| Kentucky | 1 | 2013 | 18 | 0.110 |
Why?
|
| Risk Factors | 4 | 2021 | 5608 | 0.110 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2013 | 36 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 125 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 580 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 5378 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1093 | 0.100 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 291 | 0.100 |
Why?
|
| Motor Activity | 1 | 2014 | 326 | 0.100 |
Why?
|
| Physicians | 1 | 2019 | 691 | 0.100 |
Why?
|
| Prognosis | 2 | 2017 | 3825 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2014 | 179 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 371 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 854 | 0.090 |
Why?
|
| Echocardiography | 1 | 2016 | 950 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 388 | 0.090 |
Why?
|
| United States | 3 | 2019 | 7188 | 0.080 |
Why?
|
| Vascular Patency | 2 | 2020 | 131 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2024 | 887 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2017 | 2345 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1500 | 0.080 |
Why?
|
| Registries | 1 | 2013 | 826 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 733 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 989 | 0.070 |
Why?
|
| Age Factors | 1 | 2012 | 1876 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 361 | 0.070 |
Why?
|
| Stroke Volume | 2 | 2021 | 482 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2017 | 2348 | 0.070 |
Why?
|
| Prevalence | 2 | 2023 | 1265 | 0.060 |
Why?
|
| Acute Disease | 2 | 2018 | 855 | 0.060 |
Why?
|
| Vascular Resistance | 1 | 2024 | 103 | 0.060 |
Why?
|
| Microcirculation | 1 | 2024 | 105 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2024 | 131 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 126 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2024 | 195 | 0.050 |
Why?
|
| Spasm | 1 | 2022 | 17 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 43 | 0.050 |
Why?
|
| Hemostasis | 1 | 2021 | 20 | 0.050 |
Why?
|
| Catheters | 1 | 2021 | 86 | 0.050 |
Why?
|
| Hemostatic Techniques | 1 | 2021 | 18 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2021 | 90 | 0.050 |
Why?
|
| Limb Salvage | 1 | 2020 | 38 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3716 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 516 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 130 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6847 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 309 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 433 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 307 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 238 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2018 | 419 | 0.040 |
Why?
|
| Creatinine | 1 | 2018 | 295 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 618 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2019 | 357 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 804 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 960 | 0.030 |
Why?
|
| Natriuretic Agents | 1 | 2015 | 2 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 882 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1898 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 91 | 0.030 |
Why?
|
| Brazil | 1 | 2014 | 77 | 0.030 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2019 | 521 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2015 | 191 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1892 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 336 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2904 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2682 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1493 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 4367 | 0.020 |
Why?
|